IP Verse

Dr. H. Ulrich Dorries opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Dr. H. Ulrich Dorries

Patent Number:
EP4011915
Title:
Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist
Applicant:
REGENERON PHARMACEUTICALS, INC.
Opposition Date:
Jul 3, 2024
Patent Number:
EP3311168
Title:
Novel Tnf Structure For Use In Therapy
Applicant:
UCB BIOPHARMA SPRL
Opposition Date:
Feb 12, 2024
Patent Number:
EP3827845
Title:
Subcutaneous Formulations Of Anti-Cd38 Antibodies And Their Uses
Applicant:
JANSSEN BIOTECH, INC.
Opposition Date:
Dec 22, 2022
Patent Number:
EP3157571
Title:
Fatty Acids And Their Use In Conjugation To Biomolecules
Applicant:
NOVARTIS AG
Opposition Date:
Aug 24, 2022
Patent Number:
EP3209783
Title:
Permanent Epigenetic Gene Silencing
Applicant:
FONDAZIONE TELETHON
Opposition Date:
Aug 24, 2022
Patent Number:
EP3470432
Title:
Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist
Applicant:
REGENERON PHARMACEUTICALS, INC.
Opposition Date:
Jul 5, 2022
Patent Number:
EP3107575
Title:
Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist
Applicant:
REGENERON PHARMACEUTICALS, INC.
Opposition Date:
May 4, 2022
Patent Number:
EP3288980
Title:
Treatment Of Pd-L1-Positive Melanoma Using An Anti-Pd-1 Antibody
Applicant:
BRISTOL-MYERS SQUIBB COMPANY
Opposition Date:
Dec 7, 2021
Patent Number:
EP3378486
Title:
Stabilized Antibody-Containing Liquid Formulations
Applicant:
CHUGAI SEIYAKU KABUSHIKI KAISHA
Opposition Date:
Dec 3, 2021
Patent Number:
EP3177645
Title:
Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of Cancer
Applicant:
LINDHOFER, HORST, DR.
Opposition Date:
Nov 17, 2021

Competitors of Dr. H. Ulrich Dorries

REGENERON PHARMACEUTICALS, INC.

GENENTECH, INC.

SANOFI BIOTECHNOLOGY

Want to track Dr. H. Ulrich Dorries?

Feel free to send us a message here and we will get back to you